Delivery Order SPE2DB22D3501-SPE2DB24FTX42
Award Date 12/19/23
Potential Completion Date 12/20/23
Potential Value $6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $8,848.00 contract is for the supply of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The delivery order does not have a set-aside designation and is to be completed by January 16, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, has a history of providing...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,796.78 order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, a firm fixed price delivery order, is for the supply of the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The total potential value of the award is $4,917.92, with a period of performance through February 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This federal contract award, valued at $1,009.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for the delivery of RUXIENCE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,204.48 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 mg/10 ml vials of the drug Ruxience. Performance will take place in Conshohocken, Pennsylvania over one day in late July 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the U.S. Armed Forces by procuring pharmaceuticals and other medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, with a firm fixed price ceiling of $4,892.20 and a period of performance through June 11, 2025. This delivery order is not associated with a set-aside program. AmerisourceBergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ruxience 500 mg/50 mL vials with a contract value of $2,935.32 and a completion date of August 5, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed-price pricing and represents a pharmaceutical supply transaction under the company's existing Indefinite Delivery Contract relationship with DLA. The place of performance is AmerisourceBergen's...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FN2M4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $10,403.20 firm fixed-price delivery order is for RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for $33,057.50. The contract has a period of performance through February 4, 2025 and is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is supplying a comprehensive range of medical products including specialty medications, generic drugs, vaccines, syringes, and other medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,436.66 firm fixed price contract is for the provision of pharmaceutical products and medical supplies to the Department of Defense. It has a completion date of February 20, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp serves...